[Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011 version)].
作者信息
Zhi Xiuyi, Wu Yilong, Ma Shenglin, Wang Tianyou, Wang Changli, Wang Jie, Shi Yuankai, Lu You, Liu Lunxu, Liu Deruo, Chen Donghong, Yang Yue, Du Xiang, Bu Hong, Zhou Qinghua, Jang Gening, Han Baohui, Cheng Gang, Cheng Ying, Jiao Shunchang
机构信息
Beijing Lung Cancer Center, Department of Thoracic Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):677-88. doi: 10.3779/j.issn.1009-3419.2012.12.01.
Abstract
摘要
相似文献
1
[Chinese guidelines on the diagnosis and treatment of primary lung cancer
(2011 version)].
Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):677-88. doi: 10.3779/j.issn.1009-3419.2012.12.01.
2
[Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition)].
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):257-287. doi: 10.3760/cma.j.cn112152-20200120-00049.
3
[The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version)].
Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):796-9.
4
[Standards for the diagnosis and treatment of primary lung cancer (2015 version) in China].
Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):67-78.
5
Validation of the simplified Chinese version of the quality of life instrument EORTC QLQ-LC43 for patients with lung cancer.
Cancer Invest. 2008 Jun;26(5):504-10. doi: 10.1080/07357900701781788.
6
[China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)].
Zhongguo Fei Ai Za Zhi. 2016 Jan;19(1):1-15. doi: 10.3779/j.issn.1009-3419.2016.01.01.
7
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)].
Zhonghua Zhong Liu Za Zhi. 2022 Jun 23;44(6):457-490. doi: 10.3760/cma.j.cn112152-20220413-00255.
8
Challenges and research opportunities for lung cancer screening in China.
Cancer Commun (Lond). 2018 Jun 7;38(1):34. doi: 10.1186/s40880-018-0305-0.
9
Caregiver burden among Chinese family caregivers of patients with lung cancer: A cross-sectional survey.
Eur J Oncol Nurs. 2018 Dec;37:74-80. doi: 10.1016/j.ejon.2018.11.003. Epub 2018 Nov 5.
10
[Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer].
Zhonghua Bing Li Xue Za Zhi. 2022 Nov 8;51(11):1094-1103. doi: 10.3760/cma.j.cn112151-20220606-00491.
引用本文的文献
1
TMSB4X: A novel prognostic marker for non-small cell lung cancer.
Heliyon. 2023 Nov 4;9(11):e21505. doi: 10.1016/j.heliyon.2023.e21505. eCollection 2023 Nov.
2
Effects of high quality nursing in patients with lung cancer undergoing chemotherapy and related influence on self-care ability and pulmonary function.
Am J Transl Res. 2021 May 15;13(5):5476-5483. eCollection 2021.
3
[Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei
and Fuyuan Counties in Eastern Yunnan Province, China].
Zhongguo Fei Ai Za Zhi. 2019 Aug 20;22(8):477-487. doi: 10.3779/j.issn.1009-3419.2019.08.01.
4
[Expert Consensus on the Diagnosis and Treatment of Bone Metastasis in Lung Cancer (2019 Version)].
Zhongguo Fei Ai Za Zhi. 2019 Apr 20;22(4):187-207. doi: 10.3779/j.issn.1009-3419.2019.04.01.
5
Analysis of risk factors for stage I lung adenocarcinoma using low-dose high-resolution computed tomography.
Oncol Lett. 2018 Aug;16(2):2483-2489. doi: 10.3892/ol.2018.8921. Epub 2018 Jun 6.
6
Clinical and computed tomography findings in Chinese lung cancer patients with HIV infection: A multi-center study.
Thorac Cancer. 2017 May;8(3):238-245. doi: 10.1111/1759-7714.12429. Epub 2017 Mar 15.
7
[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].
Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):1-13. doi: 10.3779/j.issn.1009-3419.2017.01.01.
8
[Systematic Review of the Methodology Quality in Lung Cancer Screening Guidelines].
Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):692-699. doi: 10.3779/j.issn.1009-3419.2016.10.11.
9
Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.
Oncol Lett. 2016 Jun;11(6):4240-4244. doi: 10.3892/ol.2016.4508. Epub 2016 Apr 28.
10
Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study.
Clinicoecon Outcomes Res. 2016 Apr 26;8:97-111. doi: 10.2147/CEOR.S98548. eCollection 2016.
Zotero 插件